Viteva  Home logo
Supplement Safety

 Untitled 1
Selenium Research

Selenium intake and cardiovascular risk: what is new?

The influence of selenium on immune responses.

The role of selenium in chronic disease.

Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

[The effect of selenium therapy on autoimmune thyroiditis]

Selenium status of term infants fed selenium-supplemented formula in a randomized dose-response trial.

Does selenium exert cardioprotective effects against oxidative stress in myocardial ischemia?

Selenium and colon cancer--from chemoprevention to new treatment modality.

Mechanisms of selenium chemoprevention and therapy in prostate cancer.

Selenium and the prevention of prostate and colorectal cancer.

[Selenium deficiency in celiac disease: risk of autoimmune thyroid diseases]

Selenium supplementation does not improve vascular responsiveness in healthy North American men.

Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase.

Selenium supplementation in the critically ill: posology and pharmacokinetics.

Selenium and inflammation: underlying anti-inflammatory mechanisms.

[Selenium supplementation in critically ill patients: pharmacological issues and current evidence]

The effect of selenium supplementation on DTH skin responses in healthy North American men.

 Untitled 1
   Home    Terms of Use    Privacy
Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us
Copyright ©2009 Viteva